2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Incidence, Risk Factors, and Response Rate to Initial Therapy for Clostridum Difficile in Solid Organ Transplant Recipients

M. Wheeler, J. Deyo, J. Huang, R. Lee, T. Kozlowski, R. Dupuis
Incisional Hernia after Liver Transplantation: Incidence and Risk Factors

S. Zhou, D. Pagano, D. Cintorino, S. Li Petri, C. Ricotta, A. Fratti, M. Paci, F. Tuzzolino, M. Spada
Incorporating a Vascularized Composite Allograft Transplant Program into a Transplant Center

L. Irwin, C. Cetrulo, J. Winograd, A. Marquez, S. Noska, A. Israelian, H. Parker, A. Norman, J. Fishman
Incorporating Time from Donation (TFD) to the MDRD and CKD-EPI Formulas Enhances Their Performance in Kidney Donors

H. Ibrahim, S. Jackson, A. Matas, N. Issa, R. Spong, A. Kukla
Increased Duration of Dual Pegylated Interferon and Ribavirin Therapy for Genotype 1 Hepatitis C Post-Liver Transplantation Increases Sustained Virologic Response: A Retrospective Review

M. Wells, P. Marotta, M. Levstik, N. Chandok, L. Roth, V. Bain, A. Mason, B. Aljudaibi
Increased Expression of CTLA-4 and PD-1 and Restricted Functionality as Typical Features of Varizella Zoster Specific T Cells in Patients with Acute Herpes Zoster

D. Schub, E. Janssen, U. Sester, M. Sester, T. Schmidt
Increased Gene Transcripts Related to Immune Activation in Allografts but Not in Peripheral Blood of Patients with Donor-Specific Anti-HLA Antibodies Despite Lack of Histopathologic Findings of Rejection

N. Hayde, Y. Bao, J. Pullman, G. De Boccardo, M. Lubetzky, E. Akalin
Increased Incidence of Non Anastomotic Biliary Strictures in Case of Donation after Circulatory Death Versus Donation after Brain Death Liver Transplantation but Equivalent Graft and Patient Survival

N. Meurisse, S. Vanden Bussche, I. Jochmans, V. Heedfeld, R. Aerts, W. Laleman, S. Van der Merwe, C. Verslype, D. Cassiman, W. Van Steenbergen, F. Nevens, J. Pirenne, D. Monbaliu
Increased Risk of Breakthrough Infection among Cytomegalovirus Donor Positive/Recipient Negative Kidney Transplant Recipients Receiving Lower Dose Valganciclovir Prophylaxis

D. Stevens, J. Trofe-Clark, E. Blumberg, M. Wilck, B. Weikert, S. Goral, M. Bleicher, D. Sawinski, P. Abt, M. Levine, P. Porrett, R. Bloom
Increasing HLA DR Mismatches Is Associated with Inferior Kidney Allograft Outcome in Low Immune Risk Living Donor Kidney Transplant Recipients

S. Lynch, K. Tinckam, J. Kim

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z